South San Francisco,
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enhancing immunotherapy...
NGM Biopharmaceuticals, Inc.
South San Fransico,
NGM Biopharmaceuticals, Inc. is a private biotech start-up dedicated to discovering next generation medicines to treat grave diseases. Our experienced scientific team has joined forces with an impressive group of industry professionals, Nobel...
Ultragenyx Pharmaceutical Inc.
Why Join Us?
Ultragenyx is a clinical stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases with an initial focus on serious debilitating metabolic genetic diseases. Founded in...
Symic Biomedical is a private, venture-backed preclinical-stage platform biopharma company and has raised $43 million since being founded in 2012. Symic has a pipeline of novel macro-molecules that mimic structural components of the extracellular...